NWSA
62
2
CF
59
3
RRC
63
3
L
62
2
CSX
51
-2
HSY
34
3
EQT
59
2
MA
55
-7
HCP
58
4
PX
75
5
TGT
25
-24
NOV
58
3
EL
20
3
JNJ
41
2
ORLY
53
-3
VRSN
53
3
KR
34
-3
CINF
47
2
NAVI
41
-3
HAS
30
2
NWSA
62
2
CF
59
3
RRC
63
3
L
62
2
CSX
51
-2
HSY
34
3
EQT
59
2
MA
55
-7
HCP
58
4
PX
75
5
TGT
25
-24
NOV
58
3
EL
20
3
JNJ
41
2
ORLY
53
-3
VRSN
53
3
KR
34
-3
CINF
47
2
NAVI
41
-3
HAS
30
2
Financhill
Back

Spyre Therapeutics Stock Predictions

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here
Sell
40

SYRE
Spyre Therapeutics

Last Price:
27.50
Seasonality Move:
-1.09%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.

Spyre Therapeutics Stock Forecast

  • Over the next 52 weeks, Spyre Therapeutics has on average historically risen by 25.6% based on the past 8 years of stock performance.
  • Spyre Therapeutics has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%
  • Is Spyre Therapeutics Stock Undervalued?
    The current Spyre Therapeutics [SYRE] share price is $27.50. The Score for SYRE is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • SYRE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Spyre Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Spyre Therapeutics has on average historically risen by 25.6% based on the past 8 years of stock performance.

Spyre Therapeutics Stock Rating

Sell
40
Spyre Therapeutics (SYRE) is a Sell

Is Spyre Therapeutics overpriced?

  • Spyre Therapeutics has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%

Spyre Therapeutics Stock Price History

Is SYRE stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
spyre.com

52-Week Data

52-Week High:
47.97
52-Week Low:
8.75

Prediction Charts

Market Cap:
1.61B
Price in USD:
27.50
Volume:
1.24M
Beta:
2.53

Technical Analysis

SMA50:
31.20
SMA100:
29.36
SMA200:
31.23
52-Wk Change:
161.9%

Stock Predictions

  • Is Spyre Therapeutics stock public?
    Yes, Spyre Therapeutics is a publicly traded company.
  • What is the Spyre Therapeutics stock quote today?
    The Spyre Therapeutics stock price is 27.50 USD today.
  • How to buy Spyre Therapeutics stock online?
    You can buy Spyre Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-1 32.72 33.98 34.13 32.72
Nov-4 33.59 35.09 35.46 33.10
Nov-5 35.30 35.92 36.08 34.68
Nov-6 37.00 37.48 38.05 35.91
Nov-7 37.59 37.69 38.73 36.92
Nov-8 35.87 39.58 39.63 33.00
Nov-11 38.85 39.35 40.09 38.61
Nov-12 39.57 35.75 40.26 35.42
Nov-13 36.39 32.98 36.98 32.23
Nov-14 33.03 31.27 33.47 31.16
Nov-15 31.35 29.20 31.35 29.14
Nov-18 29.27 28.67 30.34 28.41
Nov-19 27.73 26.90 27.80 25.74
Nov-20 26.86 27.50 28.48 26.81

Spyre Therapeutics Earnings

Spyre Therapeutics Earnings Report: Per Share Spyre Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Spyre Therapeutics Forecast Revenue Growth

Spyre Therapeutics Stock Analysis: Historical quarterly revenues per share for Spyre Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $8.85 per share, and an increase next year of $0.14 per share.

* Spyre Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.